Benzinga
Benzinga
Benzinga
lundi, septembre 21

Aethlon Medical Inc

AEMDNASDAQ
Trade with Public
Trade with Public
$6.31
-0.47-6.93%
À la clôture: Sep 17, 5:00 PM EST
$6.62
-0.16-2.36%
Pré-ouverture: 5:24 AM EST
Fusions et acquisitions: North Immunology, Inc. ("North Immunology"), Nighthawk Merger Sub Corp., a wholly owned subsidiary of Aethlon, and Nighthawk Second Merger Sub, LLC, a wholly owned subsidiary of Aethlon. announced it will be merged with Aethlon Medical (AEMD) on Thursday, September 17, 2026 for $346.5M paid in stock
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerRapport sur les stocks

Aethlon Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Aethlon Medical (AEMD).

Price Target Range — 6 Quarters

Analyst Consensus — 1 Analysts

1Hold
Consensus RatingBuy# Analysts1Avg. Consensus PT$1438Upside to Avg. PT+21614.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Aug 14, 2025HC Wainwright & Co.Swayampakula RamakanthMaintainedNeutral$2
Jul 7, 2025HC Wainwright & Co.Swayampakula RamakanthAssumesNeutral$2
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Neutral on Aethlon Medical, Maintains $1.5 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Aethlon Medical (NASDAQ:AEMD) with a Neutral and maintains $1.5 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Assumes Aethlon Medical at Neutral, Announces Price Target of $1.5

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Aethlon Medical (NASDAQ:AEMD) with a Neutral rating and announces Price Target of $1.5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved